[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ibb
Biotech stocks surge with significant engagement, but platform stability concerns and feature delays loom. Investors are closely watching key ETF movements and director buys amidst market fluctuations.
About $ibb
This topic pertains to the $IBB, a biotechnology-focused exchange-traded fund and its related social media discussions.
Insights
- $ibb engagements is up XXX% from the previous week.
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +116%
X Month: XXXXXXX +38%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX +11%
1-Year High: XXXXXXX on 2025-05-12
1-Year Low: XXXXX on 2025-09-20
Engagements by network (24h): X: XXXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX +46%
X Months: XXXXX +134%
1-Year High: XXX on 2024-12-13
1-Year Low: XX on 2025-12-06
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $ibb in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +21%
X Months: XXX +200%
1-Year High: XXX on 2025-07-09
1-Year Low: XX on 2025-12-06
The most influential creators that mention $ibb in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BOSSTRADING0 | X | XXX | XX | XXXXX |
| @PCM_bio | X | XXXXX | X | XXXXX |
| @NightOwlBiotech | X | XXXXX | XX | XXX |
| @Jr74Ski | X | XXXXX | X | XXX |
| @BRSreality | X | XXX | X | XXX |
| @nixon786 | X | XXX | X | XX |
| @VistaPResearch | X | XXXXX | X | XX |
| @fundmyfund | X | XXXXX | X | XX |
| @LTbioinvestor | X | XXXXXX | X | XX |
| @Danilo1716501 | XX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -X%
X Year: XX% -X%
1-Year High: XXX% on 2025-02-17
1-Year Low: XX% on 2025-09-07
Most Supportive Themes:
- Community Engagement: (45%) High levels of interaction and discussion within the community.
- Content Sharing: (30%) Active sharing of relevant articles, news, and user-generated content.
- Positive Sentiment: (25%) Overwhelmingly positive feedback and supportive comments.
Most Critical Themes:
- Platform Stability: (60.5%) Concerns regarding recent outages and performance issues.
- Feature Rollout Delays: (39.5%) Frustration over the delayed release of anticipated new features.
Top $ibb Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$TENX CMO acquires around $50k at open market Catalyst: P3 Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) data H2 2026 $XBI $IBB"
X Link @BOSSTRADING0 2025-12-11T00:01Z XXX followers, XXX engagements
"Matrix-M + Hiltonol = A Universal Adjuvant Engine to power the $100B cancer vaccine market. $NVAX #Biotech $IBB $XBI .@Novavax .@oncovir"
X Link @Jr74Ski 2025-12-10T20:54Z 2044 followers, XXX engagements
"Matrix-M is a best-in-class CD8+ activator via cross-presentation. Combined w/ Hiltonols TLR3 signaling this "1+1=3" synergy solves delivery & activation. .@Novavax + .@oncovir could build a universal adjuvant engine for the $100B cancer vaccine market beating all current standards. $NVAX #Biotech $XBI $IBB"
X Link @Jr74Ski 2025-12-10T20:49Z 2044 followers, XXX engagements
"The combination of best-in-class vaccine adjuvants for optimal CD8+ and CTL generation to kill cancer/virus: TLR Agonist*** + Matrix-M Adjuvant $NVAX #Biotech $IBB $XBI ***CpG or Poly-IC:LC"
X Link @Jr74Ski 2025-12-10T17:15Z 2045 followers, XXX engagements